Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,805,243
+$5,245,215 QoQ
Shares Held
26,692
+989.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026XTX Topco Ltd holds $56,692,973 across 12 Drug Manufacturers - General names. ABBV ranks #6 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
60,566 | $9,251,456 | |
| 2 | JNJ |
Johnson & Johnson
|
36,844 | $9,006,147 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
60,352 | $8,411,258 | |
| 4 | PFE |
Pfizer Inc
|
275,144 | $7,726,043 | |
| 5 | AMGN |
Amgen Inc
|
19,756 | $6,951,148 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
26,692 | $5,805,243 | |
| 7 | MRK |
Merck & Co., Inc.
|
34,803 | $4,186,452 | |
| 8 | LLY |
ELI LILLY & Co
|
4,218 | $3,879,589 |
All Filings in ABBV
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,805,243 | 26,692 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $560,028 | 2,451 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $531,384 | 2,295 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,922,521 | 21,132 | Shares | Defined | 2025-08-12 | |
| 2023-09-30 | $1,268,947 | 8,513 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $444,750 | 2,752 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $1,516,052 | 9,352 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $308,184 | 2,857 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||